董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Sharon L. Wienbar | 女 | Independent Chair of the Board | 64 | 未披露 | 未持股 | 2026-04-03 |
| Damien McDonald | 男 | Chief Executive Officer and Director | 61 | 未披露 | 未持股 | 2026-04-03 |
| Barbara W. Bodem | 女 | Independent Director | 58 | 未披露 | 未持股 | 2026-04-03 |
| Christine Ortiz | 女 | Independent Director | 55 | 未披露 | 未持股 | 2026-04-03 |
| Brady R. Shirley | 男 | Independent Director | 60 | 未披露 | 未持股 | 2026-04-03 |
| Philip A. Okala | 女 | Independent Director | 57 | 未披露 | 未持股 | 2026-04-03 |
| Rajiv Vinnakota | 男 | Independent Director | 54 | 16.28万美元 | 未持股 | 2026-04-03 |
| A. Clayton Perfall | 男 | Independent Director | 67 | 17.78万美元 | 未持股 | 2026-04-03 |
| Liam Kelly | -- | Independent Director | 59 | 未披露 | 未持股 | 2026-04-03 |
| Angela S. Lalor | 男 | Independent Director | 60 | 未披露 | 未持股 | 2026-04-03 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Damien McDonald | 男 | Chief Executive Officer and Director | 61 | 未披露 | 未持股 | 2026-04-03 |
| Phillip Berry | 男 | Senior Vice President and Chief Financial Officer | 47 | 未披露 | 未持股 | 2026-04-03 |
| Terry D. Ross | 男 | Group President, Prevention and Recovery | 56 | 未披露 | 未持股 | 2026-04-03 |
| Louis Vogt | 男 | Group President, Reconstructive | 45 | 未披露 | 未持股 | 2026-04-03 |
| Laura Singleton | 女 | Senior Vice President and Chief Human Resources Officer | -- | 未披露 | 未持股 | 2026-04-03 |
| Bradley J. Tandy | 男 | Senior Vice President and Chief Legal Officer | 67 | 未披露 | 未持股 | 2026-04-03 |
董事简历
中英对照 | 中文 | 英文- Sharon L. Wienbar
-
Sharon L. Wienbar，Career Highlights，近期从业经历：Scale Venture Partners：合伙人（2001 – 2018年）；领导对科技公司的风险投资，并曾在众多公共和私人投资组合业务的董事会任职；面向女性的领先软件工程培训公司Hackbright Academy：首席执行官（2015 – 2016年）；Planned Parenthood Direct（前身为Kaleido Health）（私营公司），领先的女性健康应用程序：董事（2016 –至今）；Everyday Health, Inc.：董事（2014 – 2016年）；Glu移动，Inc.：董事（2007 – 2008年）；在从事风险投资职业之前，曾在多家软件公司担任高管，包括Adobe Systems，并担任贝恩公司顾问；曾任职于微软公司的风险咨询委员会；其他现任公共董事职务：Resideo Technologies, Inc.；英格麦克控股公司；过去五年担任的其他公共董事职务：Covetrus, Inc.（2020 – 2022）。
Sharon L. Wienbar,Career Highlights and Recent Business Experience:Scale Venture Partners:Partner (2001 – 2018); Led venture capital investments in technology companies and served on the boards of numerous public and private portfolio businesses;Hackbright Academy, a leading software engineering training company for women:Chief Executive Officer (2015 – 2016);Planned Parenthood Direct (formerly Kaleido Health) (private company), a leading women's health app:Director (2016 – present);Everyday Health, Inc.:Director (2014 – 2016);Glu Mobile, Inc.:Director (2007 – 2008);Prior to venture capital career, served as an executive at several software companies, including Adobe Systems, and as a consultant at Bain & Company;Served on Microsoft Inc.'s venture advisory committee; Other Current Public Directorships:Resideo Technologies, Inc.;Ingram Micro Holding Corporation; Other Public Directorships in the Past Five Years:Covetrus, Inc. (2020 – 2022). - Sharon L. Wienbar，Career Highlights，近期从业经历：Scale Venture Partners：合伙人（2001 – 2018年）；领导对科技公司的风险投资，并曾在众多公共和私人投资组合业务的董事会任职；面向女性的领先软件工程培训公司Hackbright Academy：首席执行官（2015 – 2016年）；Planned Parenthood Direct（前身为Kaleido Health）（私营公司），领先的女性健康应用程序：董事（2016 –至今）；Everyday Health, Inc.：董事（2014 – 2016年）；Glu移动，Inc.：董事（2007 – 2008年）；在从事风险投资职业之前，曾在多家软件公司担任高管，包括Adobe Systems，并担任贝恩公司顾问；曾任职于微软公司的风险咨询委员会；其他现任公共董事职务：Resideo Technologies, Inc.；英格麦克控股公司；过去五年担任的其他公共董事职务：Covetrus, Inc.（2020 – 2022）。
- Sharon L. Wienbar,Career Highlights and Recent Business Experience:Scale Venture Partners:Partner (2001 – 2018); Led venture capital investments in technology companies and served on the boards of numerous public and private portfolio businesses;Hackbright Academy, a leading software engineering training company for women:Chief Executive Officer (2015 – 2016);Planned Parenthood Direct (formerly Kaleido Health) (private company), a leading women's health app:Director (2016 – present);Everyday Health, Inc.:Director (2014 – 2016);Glu Mobile, Inc.:Director (2007 – 2008);Prior to venture capital career, served as an executive at several software companies, including Adobe Systems, and as a consultant at Bain & Company;Served on Microsoft Inc.'s venture advisory committee; Other Current Public Directorships:Resideo Technologies, Inc.;Ingram Micro Holding Corporation; Other Public Directorships in the Past Five Years:Covetrus, Inc. (2020 – 2022).
- Damien McDonald
-
Damien McDonald自2016年1月起担任董事会非执行董事。McDonald先生拥有在医疗设备领域实现价值的经过证明的往绩。McDonald先生目前是LivaNova PLC公司的首席执行官和董事会董事，此前曾担任首席运营官。LivaNova PLC是纳斯达克的一家上市公司，是心血管和神经调节解决方案的领导者。在此之前，他是纽约证券交易所上市的丹纳赫公司的集团高管和企业Vice President，该公司是一家跨国科技创新公司，收购和生产生命科学和工业产品及品牌，在那里他领导了一个价值15亿美元的牙科消费品公司集团。在他任职早期，McDonald先生是Kerr的集团总裁，在那里他和他的团队专注于建立强大的研究与开发管道，同时利用Denaher业务系统提高运营绩效。他此前也曾任职Merck&Co、强生公司和Zimmer公司。McDonald先生拥有昆士兰大学（University of Queensland）的药学和经济学学士学位，威尔士大学（University of Wales）的国际经济学硕士学位，以及瑞士洛桑国际管理学院（IMD of Lausanne）的工商管理硕士学位。
Damien McDonald has served as the CEO and an executive director of the Company since January 2017 and served as the Company's Chief Operating Officer from October through December 2016. Prior to joining the Company, Mr. McDonald was with Danaher Corporation, a global manufacturer of medical, industrial and commercial products, where he was Group President, Professional Consumables 2013 to 2016. From 2011 to 2013 Mr. McDonald served as Group President of Kerr Corporation, a subsidiary of Danaher, where he was responsible for a dental consumable business with operations in the US, Mexico, Switzerland, Italy and the Czech Republic. In 2010 Mr. McDonald undertook special projects for Danaher. From 2007 to 2010 Mr. McDonald was president, Zimmer Spine at Zimmer Holdings, where he was responsible for divisions in the US and France. From 1999 to 2007 Mr. McDonald had various roles with Johnson and Johnson. Mr. McDonald holds bachelor's degrees in pharmacy and economics from the University of Queensland in Australia, a master's degree in international economics from the University of Wales, and an M.B.A. from the Institute for Management Development in Lausanne. - Damien McDonald自2016年1月起担任董事会非执行董事。McDonald先生拥有在医疗设备领域实现价值的经过证明的往绩。McDonald先生目前是LivaNova PLC公司的首席执行官和董事会董事，此前曾担任首席运营官。LivaNova PLC是纳斯达克的一家上市公司，是心血管和神经调节解决方案的领导者。在此之前，他是纽约证券交易所上市的丹纳赫公司的集团高管和企业Vice President，该公司是一家跨国科技创新公司，收购和生产生命科学和工业产品及品牌，在那里他领导了一个价值15亿美元的牙科消费品公司集团。在他任职早期，McDonald先生是Kerr的集团总裁，在那里他和他的团队专注于建立强大的研究与开发管道，同时利用Denaher业务系统提高运营绩效。他此前也曾任职Merck&Co、强生公司和Zimmer公司。McDonald先生拥有昆士兰大学（University of Queensland）的药学和经济学学士学位，威尔士大学（University of Wales）的国际经济学硕士学位，以及瑞士洛桑国际管理学院（IMD of Lausanne）的工商管理硕士学位。
- Damien McDonald has served as the CEO and an executive director of the Company since January 2017 and served as the Company's Chief Operating Officer from October through December 2016. Prior to joining the Company, Mr. McDonald was with Danaher Corporation, a global manufacturer of medical, industrial and commercial products, where he was Group President, Professional Consumables 2013 to 2016. From 2011 to 2013 Mr. McDonald served as Group President of Kerr Corporation, a subsidiary of Danaher, where he was responsible for a dental consumable business with operations in the US, Mexico, Switzerland, Italy and the Czech Republic. In 2010 Mr. McDonald undertook special projects for Danaher. From 2007 to 2010 Mr. McDonald was president, Zimmer Spine at Zimmer Holdings, where he was responsible for divisions in the US and France. From 1999 to 2007 Mr. McDonald had various roles with Johnson and Johnson. Mr. McDonald holds bachelor's degrees in pharmacy and economics from the University of Queensland in Australia, a master's degree in international economics from the University of Wales, and an M.B.A. from the Institute for Management Development in Lausanne.
- Barbara W. Bodem
-
BarbaraW.Bodem高级副总裁和首席财务官当选，自2018年12月起生效。加入Hillrom公司之前，她曾担任Mallinckrodt公司的高级副总裁，财务。此前，她曾担任好比拉医疗保健公司和礼来公司（Eli Lilly）的多种高级财务职务，包括礼来肿瘤公司的首席财务官。
Barbara W. Bodem,was interim Chief Financial Officer of Dentsply Sirona Inc., a public dental equipment and supplies manufacturing company, from April 2022 to October 2022. Prior to that, she served as Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc., a medical device and medical technology provider, from 2018 until its acquisition by Baxter International Inc. in 2021. Earlier in her career, she served as Senior Vice President of Finance of Mallinckrodt Pharmaceuticals, a pharmaceutical manufacturer, from 2015 to 2018. She previously served in senior finance roles at Hospira, Inc. and Eli Lilly and Company.Ms. Bodem currently serves on the boards of Enovis Corp., a public medical technology company, and Option Care Health, Inc., a public provider of home and alternate site infusion services. She also serves on the boards of BiomEdit LLC, a private animal health company, NorthStar Medical Radioisotopes, a radiopharmaceutical company and the non-profit Nature Conservancy of Indiana. In the past five years, Ms. Bodem served on the boards of Syneos Health, Inc. and Turning Point Therapeutics, Inc. She also served on the board of Invacare Corporation.She holds a B.S. in Finance and an M.B.A from Indiana University. - BarbaraW.Bodem高级副总裁和首席财务官当选，自2018年12月起生效。加入Hillrom公司之前，她曾担任Mallinckrodt公司的高级副总裁，财务。此前，她曾担任好比拉医疗保健公司和礼来公司（Eli Lilly）的多种高级财务职务，包括礼来肿瘤公司的首席财务官。
- Barbara W. Bodem,was interim Chief Financial Officer of Dentsply Sirona Inc., a public dental equipment and supplies manufacturing company, from April 2022 to October 2022. Prior to that, she served as Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc., a medical device and medical technology provider, from 2018 until its acquisition by Baxter International Inc. in 2021. Earlier in her career, she served as Senior Vice President of Finance of Mallinckrodt Pharmaceuticals, a pharmaceutical manufacturer, from 2015 to 2018. She previously served in senior finance roles at Hospira, Inc. and Eli Lilly and Company.Ms. Bodem currently serves on the boards of Enovis Corp., a public medical technology company, and Option Care Health, Inc., a public provider of home and alternate site infusion services. She also serves on the boards of BiomEdit LLC, a private animal health company, NorthStar Medical Radioisotopes, a radiopharmaceutical company and the non-profit Nature Conservancy of Indiana. In the past five years, Ms. Bodem served on the boards of Syneos Health, Inc. and Turning Point Therapeutics, Inc. She also served on the board of Invacare Corporation.She holds a B.S. in Finance and an M.B.A from Indiana University.
- Christine Ortiz
-
Christine Ortiz是麻省理工学院的莫里斯·科恩材料科学与工程教授。她是180多种学术出版物的作者，曾监管跨多个学术学科的研究项目，获得30个国家和国际荣誉，包括George W.Bush总统授予她的科学和工程总统早期职业奖，并于2010年至2016年担任麻省理工学院研究生教育院长。她也是一个创新的、非营利的、中学后教育机构——1号站的创始人。Ortiz博士在伦斯勒理工学院（Rensselaer Polytechnic Institute）获得理学学士学位，并在康奈尔大学（Cornell University）获得理学硕士学位和哲学博士学位，分别在材料科学和工程领域。
Christine Ortiz has been a member of Board of Directors since November 2018. Dr. Ortiz is the Morris Cohen Professor of Materials Science and Engineering at the Massachetts Institute of Technology and Director of the MIT Technology and Policy Program. The author of more than 200 scholarly publications, she has supervised research projects across multiple academic disciplines, received 30 national and international honors, including the Presidential Early Career Award in Science and Engineering awarded to her by President George W. Bh, and served as the Dean for Graduate Education at Massachetts Institute of Technology from 2010 to 2016. She is also the founder of an innovative, nonprofit, higher education institution, Station1. Dr. Ortiz has served as a director of Enovis Corporation since 2022. She earned a Bachelor of Science degree from Rensselaer Polytechnic Institute and a Master of Science degree and a Doctor of Philosophy degree from Cornell University, each in the field of materials science and engineering. - Christine Ortiz是麻省理工学院的莫里斯·科恩材料科学与工程教授。她是180多种学术出版物的作者，曾监管跨多个学术学科的研究项目，获得30个国家和国际荣誉，包括George W.Bush总统授予她的科学和工程总统早期职业奖，并于2010年至2016年担任麻省理工学院研究生教育院长。她也是一个创新的、非营利的、中学后教育机构——1号站的创始人。Ortiz博士在伦斯勒理工学院（Rensselaer Polytechnic Institute）获得理学学士学位，并在康奈尔大学（Cornell University）获得理学硕士学位和哲学博士学位，分别在材料科学和工程领域。
- Christine Ortiz has been a member of Board of Directors since November 2018. Dr. Ortiz is the Morris Cohen Professor of Materials Science and Engineering at the Massachetts Institute of Technology and Director of the MIT Technology and Policy Program. The author of more than 200 scholarly publications, she has supervised research projects across multiple academic disciplines, received 30 national and international honors, including the Presidential Early Career Award in Science and Engineering awarded to her by President George W. Bh, and served as the Dean for Graduate Education at Massachetts Institute of Technology from 2010 to 2016. She is also the founder of an innovative, nonprofit, higher education institution, Station1. Dr. Ortiz has served as a director of Enovis Corporation since 2022. She earned a Bachelor of Science degree from Rensselaer Polytechnic Institute and a Master of Science degree and a Doctor of Philosophy degree from Cornell University, each in the field of materials science and engineering.
- Brady R. Shirley
-
BradyR.Shirley于2016年11月被任命为DJO首席执行官。在此之前，Shirley先生于2014年3月被任命为DJO Surgical Business的总裁。Shirley从2009年到2013年担任Innovative Medical Device Solutions“；IMDS”；首席执行官和董事，该公司为骨科医疗器械行业的医疗器械公司提供全面的产品开发、制造和供应链管理解决方案。在IMDS，Shirley先生管理着四家公司的整合，巩固了资本结构并在2013年领导了该业务的成功出售。Shirley从1992年12月到2009年8月在史赛克公司担任多个重要领导职位，包括Stryker Communications总裁和Stryker Endoscope高级副总裁。Shirley先生在奥斯汀德克萨斯大学（University of Texas，Austin）获得金融学工商管理学士学位。
Brady R. Shirley,Career Highlights and Recent Business Experience:Enovis Corporation:Executive Advisor (2024 – March 2025);President and Chief Operating Officer (2022 – 2024);Chief Executive Officer, DJO business (2016 – 2022);President, DJO Surgical business (2014 – 2016);National Seating & Mobility (private company):Chair of the Board of Directors (2023 – present);Innovative Medical Device Solutions:Chief Executive Officer and Director (2009 – 2013);Stryker Corporation (1992 – 2009):Served in several key leadership positions, including President of Stryker Communications and Senior Vice President of Stryker Endoscopy. - BradyR.Shirley于2016年11月被任命为DJO首席执行官。在此之前，Shirley先生于2014年3月被任命为DJO Surgical Business的总裁。Shirley从2009年到2013年担任Innovative Medical Device Solutions“；IMDS”；首席执行官和董事，该公司为骨科医疗器械行业的医疗器械公司提供全面的产品开发、制造和供应链管理解决方案。在IMDS，Shirley先生管理着四家公司的整合，巩固了资本结构并在2013年领导了该业务的成功出售。Shirley从1992年12月到2009年8月在史赛克公司担任多个重要领导职位，包括Stryker Communications总裁和Stryker Endoscope高级副总裁。Shirley先生在奥斯汀德克萨斯大学（University of Texas，Austin）获得金融学工商管理学士学位。
- Brady R. Shirley,Career Highlights and Recent Business Experience:Enovis Corporation:Executive Advisor (2024 – March 2025);President and Chief Operating Officer (2022 – 2024);Chief Executive Officer, DJO business (2016 – 2022);President, DJO Surgical business (2014 – 2016);National Seating & Mobility (private company):Chair of the Board of Directors (2023 – present);Innovative Medical Device Solutions:Chief Executive Officer and Director (2009 – 2013);Stryker Corporation (1992 – 2009):Served in several key leadership positions, including President of Stryker Communications and Senior Vice President of Stryker Endoscopy.
- Philip A. Okala
-
Philip A. Okala，Career Highlights及近期业务经历：塔夫茨医药；首席运营官（2023 –至今）；希望之城（一家领先的癌症研究和治疗机构）；系统总裁（2022 – 2023）；宾夕法尼亚大学卫生系统；首席运营官（2017 – 2022）；战略和业务发展高级副总裁（2013 – 2017）；服务线副总裁（2007 – 2013）；曾在其他医疗保健组织担任管理和领导职务，包括Geisinger Health System、Roswell Park Cancer Institute和德克萨斯大学MD Anderson Cancer Center；美国医疗保健高管学院和医疗保健财务管理协会研究员。
Philip A. Okala,Career Highlights and Recent Business Experience:Tufts Medicine;Chief Operating Officer (2023 – present);City of Hope (a leading cancer research and treatment organization);System President (2022 – 2023);University of Pennsylvania Health System;Chief Operating Officer (2017 – 2022);Senior Vice President for Strategy and Business Development (2013 – 2017);Vice President for Service Lines (2007 – 2013);Previously held management and leadership positions with other healthcare organizations, including Geisinger Health System, Roswell Park Cancer Institute and the University of Texas MD Anderson Cancer Center;Fellow in the American College of Healthcare Executives and The Healthcare Financial Management Association. - Philip A. Okala，Career Highlights及近期业务经历：塔夫茨医药；首席运营官（2023 –至今）；希望之城（一家领先的癌症研究和治疗机构）；系统总裁（2022 – 2023）；宾夕法尼亚大学卫生系统；首席运营官（2017 – 2022）；战略和业务发展高级副总裁（2013 – 2017）；服务线副总裁（2007 – 2013）；曾在其他医疗保健组织担任管理和领导职务，包括Geisinger Health System、Roswell Park Cancer Institute和德克萨斯大学MD Anderson Cancer Center；美国医疗保健高管学院和医疗保健财务管理协会研究员。
- Philip A. Okala,Career Highlights and Recent Business Experience:Tufts Medicine;Chief Operating Officer (2023 – present);City of Hope (a leading cancer research and treatment organization);System President (2022 – 2023);University of Pennsylvania Health System;Chief Operating Officer (2017 – 2022);Senior Vice President for Strategy and Business Development (2013 – 2017);Vice President for Service Lines (2007 – 2013);Previously held management and leadership positions with other healthcare organizations, including Geisinger Health System, Roswell Park Cancer Institute and the University of Texas MD Anderson Cancer Center;Fellow in the American College of Healthcare Executives and The Healthcare Financial Management Association.
- Rajiv Vinnakota
-
Rajiv Vinnakota，自2008年5月13日担任了公司的董事。自1997年以来，他是SEED基金，一家非盈利教育组织的联合创始人兼首席执行官。1997年到2006年，Vinnakota担任SEED 基金会董事会的主席。在成为SEED联合创始人之前，Vinnakota 先生是美国美智管理顾问公司的合伙人。2004年到2007年，他也是普林斯顿大学的委托人，以及2006年到2007年担任普林斯顿大学董事会的执行委员会成员，2007年到2009年，他担任普林斯顿大学年度捐赠委员会的主席。
Rajiv Vinnakota,He is Institute for Citizens & Scholars (formerly the Woodrow Wilson National Fellowship Foundation):President (2019 – present);The Aspen Institute:Executive Vice President (2015 – 2018), leading a division on youth and engagement;The SEED Foundation:Co-Founder and Chief Executive Officer (1997 – 2015);Director (1997 – present); Chair of the Board (1997 – 2005);Princeton University:Trustee (2004 – 2007);Member, Executive Committee of Board of Directors (2006 – 2007);National Chair of Annual Giving (2007 – 2009);The Eugene and Agnes Meyer Foundation:Director (2016 – 2019);Previously served as an associate at Mercer Management Consulting; Other Current Public Directorships:ESAB Corporation (2022 – present). - Rajiv Vinnakota，自2008年5月13日担任了公司的董事。自1997年以来，他是SEED基金，一家非盈利教育组织的联合创始人兼首席执行官。1997年到2006年，Vinnakota担任SEED 基金会董事会的主席。在成为SEED联合创始人之前，Vinnakota 先生是美国美智管理顾问公司的合伙人。2004年到2007年，他也是普林斯顿大学的委托人，以及2006年到2007年担任普林斯顿大学董事会的执行委员会成员，2007年到2009年，他担任普林斯顿大学年度捐赠委员会的主席。
- Rajiv Vinnakota,He is Institute for Citizens & Scholars (formerly the Woodrow Wilson National Fellowship Foundation):President (2019 – present);The Aspen Institute:Executive Vice President (2015 – 2018), leading a division on youth and engagement;The SEED Foundation:Co-Founder and Chief Executive Officer (1997 – 2015);Director (1997 – present); Chair of the Board (1997 – 2005);Princeton University:Trustee (2004 – 2007);Member, Executive Committee of Board of Directors (2006 – 2007);National Chair of Annual Giving (2007 – 2009);The Eugene and Agnes Meyer Foundation:Director (2016 – 2019);Previously served as an associate at Mercer Management Consulting; Other Current Public Directorships:ESAB Corporation (2022 – present).
- A. Clayton Perfall
-
A. Clayton Perfall， 他是公司的董事（2010年9月21日以来）。他目前担任Tailwind Capital公司（私人股本基金管理公司，专注于医疗保健和商业和通信服务行业的中产市场企业）的运营执行官。他此前曾担任Archway Marketing Services公司（营销物流和实现服务供应商）的主席兼首席执行官（从2008年到2013年）。从2001年到2008年，他曾担任AHL Services公司的首席执行官兼董事会成员。他也曾担任Union Street Acquisition公司的首席执行官（从2006年到2008年）。他曾担任Snyder Communications公司的首席财务官（从1996年到2000年），此前也曾担任一个大型国际会计公司的合伙人。他目前任职于RT Acquisition公司和Comstock Holding Companies的董事会。他此前曾任职于Archway Marketing Services公司（从2008年到2013年）和inVentiv Health公司的董事会（从1999年到2010年）。他目前是Comstock Homebuilding Companies的审计委员会主席，也曾担任inVentiv Health公司的审计委员会主席。
A. Clayton Perfall,Career Highlights and Recent Business Experience:Tailwind Capital (2014 – 2022):Operating Executive, focused on growing middle market companies in the healthcare, technology, business services and industrial services sectors;Archway Marketing Services, Inc.:Chairman and Chief Executive Officer (2008 – 2013);Union Street Acquisition Corp.:Chief Executive Officer and Director (2006 – 2008);AHL Services, Inc.:Chief Executive Officer and Director (2001 – 2008);Snyder Communications, Inc.:Chief Financial Officer and Director (1996 – 2000);Previously served as a partner with an international accounting firm, and as a director of numerous public and private companies. - A. Clayton Perfall， 他是公司的董事（2010年9月21日以来）。他目前担任Tailwind Capital公司（私人股本基金管理公司，专注于医疗保健和商业和通信服务行业的中产市场企业）的运营执行官。他此前曾担任Archway Marketing Services公司（营销物流和实现服务供应商）的主席兼首席执行官（从2008年到2013年）。从2001年到2008年，他曾担任AHL Services公司的首席执行官兼董事会成员。他也曾担任Union Street Acquisition公司的首席执行官（从2006年到2008年）。他曾担任Snyder Communications公司的首席财务官（从1996年到2000年），此前也曾担任一个大型国际会计公司的合伙人。他目前任职于RT Acquisition公司和Comstock Holding Companies的董事会。他此前曾任职于Archway Marketing Services公司（从2008年到2013年）和inVentiv Health公司的董事会（从1999年到2010年）。他目前是Comstock Homebuilding Companies的审计委员会主席，也曾担任inVentiv Health公司的审计委员会主席。
- A. Clayton Perfall,Career Highlights and Recent Business Experience:Tailwind Capital (2014 – 2022):Operating Executive, focused on growing middle market companies in the healthcare, technology, business services and industrial services sectors;Archway Marketing Services, Inc.:Chairman and Chief Executive Officer (2008 – 2013);Union Street Acquisition Corp.:Chief Executive Officer and Director (2006 – 2008);AHL Services, Inc.:Chief Executive Officer and Director (2001 – 2008);Snyder Communications, Inc.:Chief Financial Officer and Director (1996 – 2000);Previously served as a partner with an international accounting firm, and as a director of numerous public and private companies.
- Liam Kelly
-
Liam Kelly，职业亮点和最近的商业经验：Teleflex Incorporated；董事长、总裁兼首席执行官（2020年至今）；总裁兼首席执行官（2018 - 2020）；2009年至2017年担任各种高级领导职务；Hill-Rom Holdings, Inc. （2002 - 2009）；曾担任多个高级职位，包括国际营销和研发副总裁。其他现任公共董事：Teleflex Incorporated（2020年至今）。
Liam Kelly,Career Highlights and Recent Business Experience:Teleflex Incorporated;Chairman, President and Chief Executive Officer (2020 – present);President and Chief Executive Officer (2018 – 2020);Served in a variety of senior leadership roles from 2009 to 2017;Hill-Rom Holdings, Inc. (2002 – 2009);Served in a number of senior level positions, including Vice President of International Marketing and R&D. Other Current Public Directorships:Teleflex Incorporated (2020 – present). - Liam Kelly，职业亮点和最近的商业经验：Teleflex Incorporated；董事长、总裁兼首席执行官（2020年至今）；总裁兼首席执行官（2018 - 2020）；2009年至2017年担任各种高级领导职务；Hill-Rom Holdings, Inc. （2002 - 2009）；曾担任多个高级职位，包括国际营销和研发副总裁。其他现任公共董事：Teleflex Incorporated（2020年至今）。
- Liam Kelly,Career Highlights and Recent Business Experience:Teleflex Incorporated;Chairman, President and Chief Executive Officer (2020 – present);President and Chief Executive Officer (2018 – 2020);Served in a variety of senior leadership roles from 2009 to 2017;Hill-Rom Holdings, Inc. (2002 – 2009);Served in a number of senior level positions, including Vice President of International Marketing and R&D. Other Current Public Directorships:Teleflex Incorporated (2020 – present).
- Angela S. Lalor
-
Angela S. Lalor 自 2012 年加入Danaher 以来，一直担任人力资源高级副总裁。
Angela S. Lalor has served as Senior Vice President - Human Resources since joining Danaher in 2012. - Angela S. Lalor 自 2012 年加入Danaher 以来，一直担任人力资源高级副总裁。
- Angela S. Lalor has served as Senior Vice President - Human Resources since joining Danaher in 2012.
高管简历
中英对照 | 中文 | 英文- Damien McDonald
Damien McDonald自2016年1月起担任董事会非执行董事。McDonald先生拥有在医疗设备领域实现价值的经过证明的往绩。McDonald先生目前是LivaNova PLC公司的首席执行官和董事会董事，此前曾担任首席运营官。LivaNova PLC是纳斯达克的一家上市公司，是心血管和神经调节解决方案的领导者。在此之前，他是纽约证券交易所上市的丹纳赫公司的集团高管和企业Vice President，该公司是一家跨国科技创新公司，收购和生产生命科学和工业产品及品牌，在那里他领导了一个价值15亿美元的牙科消费品公司集团。在他任职早期，McDonald先生是Kerr的集团总裁，在那里他和他的团队专注于建立强大的研究与开发管道，同时利用Denaher业务系统提高运营绩效。他此前也曾任职Merck&Co、强生公司和Zimmer公司。McDonald先生拥有昆士兰大学（University of Queensland）的药学和经济学学士学位，威尔士大学（University of Wales）的国际经济学硕士学位，以及瑞士洛桑国际管理学院（IMD of Lausanne）的工商管理硕士学位。
Damien McDonald has served as the CEO and an executive director of the Company since January 2017 and served as the Company's Chief Operating Officer from October through December 2016. Prior to joining the Company, Mr. McDonald was with Danaher Corporation, a global manufacturer of medical, industrial and commercial products, where he was Group President, Professional Consumables 2013 to 2016. From 2011 to 2013 Mr. McDonald served as Group President of Kerr Corporation, a subsidiary of Danaher, where he was responsible for a dental consumable business with operations in the US, Mexico, Switzerland, Italy and the Czech Republic. In 2010 Mr. McDonald undertook special projects for Danaher. From 2007 to 2010 Mr. McDonald was president, Zimmer Spine at Zimmer Holdings, where he was responsible for divisions in the US and France. From 1999 to 2007 Mr. McDonald had various roles with Johnson and Johnson. Mr. McDonald holds bachelor's degrees in pharmacy and economics from the University of Queensland in Australia, a master's degree in international economics from the University of Wales, and an M.B.A. from the Institute for Management Development in Lausanne.- Damien McDonald自2016年1月起担任董事会非执行董事。McDonald先生拥有在医疗设备领域实现价值的经过证明的往绩。McDonald先生目前是LivaNova PLC公司的首席执行官和董事会董事，此前曾担任首席运营官。LivaNova PLC是纳斯达克的一家上市公司，是心血管和神经调节解决方案的领导者。在此之前，他是纽约证券交易所上市的丹纳赫公司的集团高管和企业Vice President，该公司是一家跨国科技创新公司，收购和生产生命科学和工业产品及品牌，在那里他领导了一个价值15亿美元的牙科消费品公司集团。在他任职早期，McDonald先生是Kerr的集团总裁，在那里他和他的团队专注于建立强大的研究与开发管道，同时利用Denaher业务系统提高运营绩效。他此前也曾任职Merck&Co、强生公司和Zimmer公司。McDonald先生拥有昆士兰大学（University of Queensland）的药学和经济学学士学位，威尔士大学（University of Wales）的国际经济学硕士学位，以及瑞士洛桑国际管理学院（IMD of Lausanne）的工商管理硕士学位。
- Damien McDonald has served as the CEO and an executive director of the Company since January 2017 and served as the Company's Chief Operating Officer from October through December 2016. Prior to joining the Company, Mr. McDonald was with Danaher Corporation, a global manufacturer of medical, industrial and commercial products, where he was Group President, Professional Consumables 2013 to 2016. From 2011 to 2013 Mr. McDonald served as Group President of Kerr Corporation, a subsidiary of Danaher, where he was responsible for a dental consumable business with operations in the US, Mexico, Switzerland, Italy and the Czech Republic. In 2010 Mr. McDonald undertook special projects for Danaher. From 2007 to 2010 Mr. McDonald was president, Zimmer Spine at Zimmer Holdings, where he was responsible for divisions in the US and France. From 1999 to 2007 Mr. McDonald had various roles with Johnson and Johnson. Mr. McDonald holds bachelor's degrees in pharmacy and economics from the University of Queensland in Australia, a master's degree in international economics from the University of Wales, and an M.B.A. from the Institute for Management Development in Lausanne.
- Phillip Berry
Phillip Berry，在医疗技术领域与诺华/爱尔康共度了18年，其中包括在2019年作为一家独立的上市公司推出了爱尔康。在爱尔康任职期间，Berry先生担任过财务领导职务，在战略、运营和业务流程改进方面的责任越来越大。Berry先生拥有肯尼索州立大学工商管理硕士学位。
Phillip Berry,spent 18 years in the medical technologies sector with Novartis/Alcon, which included its launch of Alcon as an independent public company in 2019. During his tenure at Alcon, Mr. Berry served in finance leadership roles of increasing responsibility in strategy, operations and business process improvement. Mr. Berry holds a master's degree in business administration from Kennesaw State University.- Phillip Berry，在医疗技术领域与诺华/爱尔康共度了18年，其中包括在2019年作为一家独立的上市公司推出了爱尔康。在爱尔康任职期间，Berry先生担任过财务领导职务，在战略、运营和业务流程改进方面的责任越来越大。Berry先生拥有肯尼索州立大学工商管理硕士学位。
- Phillip Berry,spent 18 years in the medical technologies sector with Novartis/Alcon, which included its launch of Alcon as an independent public company in 2019. During his tenure at Alcon, Mr. Berry served in finance leadership roles of increasing responsibility in strategy, operations and business process improvement. Mr. Berry holds a master's degree in business administration from Kennesaw State University.
- Terry D. Ross
Terry D. Ross，曾在丹纳赫和GE担任多个管理职务。罗斯先生获得了哈佛商学院的MBA学位，并以贝克学者的身份毕业，并获得了西弗吉尼亚大学的机械工程学士学位。
Terry D. Ross,served in a number of management roles at Danaher and GE. Mr. Ross earned an MBA from Harvard Business School, graduating as a Baker Scholar, and received a B.S. in Mechanical Engineering from West Virginia University.- Terry D. Ross，曾在丹纳赫和GE担任多个管理职务。罗斯先生获得了哈佛商学院的MBA学位，并以贝克学者的身份毕业，并获得了西弗吉尼亚大学的机械工程学士学位。
- Terry D. Ross,served in a number of management roles at Danaher and GE. Mr. Ross earned an MBA from Harvard Business School, graduating as a Baker Scholar, and received a B.S. in Mechanical Engineering from West Virginia University.
- Louis Vogt
Louis Vogt曾在Zimmer和齐默巴奥米特控工作了15年，担任过多个商业领导职务，涵盖侦察、创伤、运动医学和骨科生物制剂部门的销售、营销和产品管理。Vogt先生在圣母大学获得MBA学位，在普渡大学获得商业管理学士学位。
Louis Vogt,spent 15 years with Zimmer and Zimmer Biomet in various commercial leadership roles spanning sales, marketing and product management across their Recon, Trauma, Sports Medicine, and Ortho Biologics divisions. Mr. Vogt earned his MBA from the University of Notre Dame and a B.S. degree in Business Management from Purdue University.- Louis Vogt曾在Zimmer和齐默巴奥米特控工作了15年，担任过多个商业领导职务，涵盖侦察、创伤、运动医学和骨科生物制剂部门的销售、营销和产品管理。Vogt先生在圣母大学获得MBA学位，在普渡大学获得商业管理学士学位。
- Louis Vogt,spent 15 years with Zimmer and Zimmer Biomet in various commercial leadership roles spanning sales, marketing and product management across their Recon, Trauma, Sports Medicine, and Ortho Biologics divisions. Mr. Vogt earned his MBA from the University of Notre Dame and a B.S. degree in Business Management from Purdue University.
- Laura Singleton
Laura Singleton，于2019年2月因公司收购DJO Global而加入公司，她自2017年10月起担任人力资源副总裁。在此之前，她曾在Toppan Photomasks，Inc.、Ixia和Millennium Laboratories担任过一系列人力资源高级领导职务。辛格尔顿女士获得得克萨斯州立大学历史学学士学位。
Laura Singleton,joined the Company in February 2019 in connection with the Company's acquisition of DJO Global, where she had served in vice president of human resources roles since October 2017. Prior to that, she held a series of human resources senior leadership roles at Toppan Photomasks, Inc., Ixia, and Millennium Laboratories. Ms. Singleton earned a B.A. degree in history from Texas State University.- Laura Singleton，于2019年2月因公司收购DJO Global而加入公司，她自2017年10月起担任人力资源副总裁。在此之前，她曾在Toppan Photomasks，Inc.、Ixia和Millennium Laboratories担任过一系列人力资源高级领导职务。辛格尔顿女士获得得克萨斯州立大学历史学学士学位。
- Laura Singleton,joined the Company in February 2019 in connection with the Company's acquisition of DJO Global, where she had served in vice president of human resources roles since October 2017. Prior to that, she held a series of human resources senior leadership roles at Toppan Photomasks, Inc., Ixia, and Millennium Laboratories. Ms. Singleton earned a B.A. degree in history from Texas State University.
- Bradley J. Tandy
Bradley J. Tandy自2019年7月起担任高级副总裁兼总法律顾问。从2019年2月到2019年6月，他担任我们的临时总法律顾问。Tandy先生还继续担任DJO的执行副总裁、总法律顾问和秘书。在加入DJO之前，Tandy先生于2006年至2014年担任Biomet，Inc.的高级副总裁、总法律顾问和秘书。在担任总法律顾问之前，Brad于1999年至2006年担任Biomet的副总裁、助理总法律顾问和首席合规官。他于1992年加入Biomet，担任助理总法律顾问。在加入Biomet之前，Tandy先生是印第安纳州华沙Rasor，Harris，Lemon & Reed律师事务所的合伙人，专注于代表医疗器械和医疗保健公司。他是印第安纳州科修斯科县的民选公职人员，担任县议员长达22年。他在DePauw大学获得政治学学士学位，并在印第安纳州布卢明顿的印第安纳大学法学院获得法学博士学位。
Bradley J. Tandy,served as Senior Vice President, General Counsel and Secretary of Biomet, Inc. from 2006 through 2014. Prior to serving as General Counsel, Mr. Tandy served as Vice President, Assistant General Counsel and Chief Compliance Officer of Biomet from 1999 through 2006. He joined Biomet as Assistant General Counsel in 1992. Prior to his employment at Biomet, Mr. Tandy was a partner in the law firm of Rasor, Harris, Lemon & Reed in Warsaw, Indiana, focusing his practice on representation of medical device and healthcare companies. He was an elected public official in Kosciusko County, Indiana, serving as a County Councilman for 22 years. He received his undergraduate degree in Political Science from DePauw University and earned his Doctorate of Jurisprudence at Indiana University School of Law in Bloomington, Indiana.- Bradley J. Tandy自2019年7月起担任高级副总裁兼总法律顾问。从2019年2月到2019年6月，他担任我们的临时总法律顾问。Tandy先生还继续担任DJO的执行副总裁、总法律顾问和秘书。在加入DJO之前，Tandy先生于2006年至2014年担任Biomet，Inc.的高级副总裁、总法律顾问和秘书。在担任总法律顾问之前，Brad于1999年至2006年担任Biomet的副总裁、助理总法律顾问和首席合规官。他于1992年加入Biomet，担任助理总法律顾问。在加入Biomet之前，Tandy先生是印第安纳州华沙Rasor，Harris，Lemon & Reed律师事务所的合伙人，专注于代表医疗器械和医疗保健公司。他是印第安纳州科修斯科县的民选公职人员，担任县议员长达22年。他在DePauw大学获得政治学学士学位，并在印第安纳州布卢明顿的印第安纳大学法学院获得法学博士学位。
- Bradley J. Tandy,served as Senior Vice President, General Counsel and Secretary of Biomet, Inc. from 2006 through 2014. Prior to serving as General Counsel, Mr. Tandy served as Vice President, Assistant General Counsel and Chief Compliance Officer of Biomet from 1999 through 2006. He joined Biomet as Assistant General Counsel in 1992. Prior to his employment at Biomet, Mr. Tandy was a partner in the law firm of Rasor, Harris, Lemon & Reed in Warsaw, Indiana, focusing his practice on representation of medical device and healthcare companies. He was an elected public official in Kosciusko County, Indiana, serving as a County Councilman for 22 years. He received his undergraduate degree in Political Science from DePauw University and earned his Doctorate of Jurisprudence at Indiana University School of Law in Bloomington, Indiana.